Content
Tuesday Talk: Market Stays Steady
Article By:
David Marshall
Read
Tuesday, May 14, 2024 5:01 AM EDT
With turmoil in the Kremlin and no movement towards a ceasefire in the Middle East the market maintained a steady course on Monday, ahead of data dumps later in the week.
J&J: A Healthy Dose Of Income And Growth
Article By:
MoneyShow.com
Read
Tuesday, May 14, 2024 3:30 AM EDT
Johnson & Johnson (JNJ)— founded in 1886 — is a diversified healthcare company and a leader in the area of innovative medicine and medical devices.
In this article: JNJ
2 Intriguing Medical Stocks To Buy For Steady Growth As Earnings Approach
Article By:
Zacks Investment Research
Read
Tuesday, May 14, 2024 2:10 AM EDT
Among the medical sector, Alcon and Prestige Consumer Healthcare are two intriguing stocks to buy for growth as their quarterly results approach on Tuesday, May 14.
Current Analysis: Sweden-Based, Elekta AB
Article By:
Fredrik Arnold
Read
Monday, May 13, 2024 9:50 PM EDT
Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy, including stereotactic radiosurgery and brachytherapy. Over the past year, Elekta's share price fell about 9.4%.
In this article: EKTAF
Bear Of The Day: H&E Equipment Services, Inc.
Article By:
Benjamin Rains
Read
Monday, May 13, 2024 7:58 AM EDT
HEES is coming under some pressure amid a “transitioning business environment.” H&E Equipment fell short of our bottom lines estimate on April 30 and provided downbeat earnings guidance that helps it grab a Zacks Rank #5 (Strong Sell) at the moment.
In this article: HEES
Warner Bros. Discovery Posts $9.96 Billion In Q1 Revenues, Missing Estimates Amid Strategic Shifts
Article By:
ValueWalk
Read
Monday, May 13, 2024 7:56 AM EDT
WB Discovery had a number of challenges in the first quarter and failed to meet its anticipated sales and earnings targets. The company announced a $0.40 per share loss on $9.96 billion in revenues, which was less than the predicted $10.231 billion.
In this article: WBD
Dax Forecast: Continues To Climb
Article By:
Christopher Lewis
Read
Monday, May 13, 2024 7:44 AM EDT
The DAX has been rather bullish for some time now and it took off again during the trading session on Friday.
It looks like the 18,800 euro level is giving a little bit of resistance, but this is a market that you have no business being short of.
In this article: DAX
Investors Don’t Like Their Corn… [Dirty Dozen]
Article By:
Macro-Ops
Read
Monday, May 13, 2024 7:04 AM EDT
In this week’s Dirty Dozen [CHART PACK] we talk about key levels in Qs and crypto, discuss the start of some negative divergences in internals, look at a breakout in corn, and pitch a potash producer as a way to play a bottom in softs, plus more…
Bull Of The Day: Veeva Systems
Article By:
Benjamin Rains
Read
Monday, May 13, 2024 5:21 AM EDT
Veeva’s various cloud software offerings serve vital segments of the economy from pharmaceutical giants to biotech upstarts.
In this article: VEEV
“I See No ‘Stag’ Nor ‘Flation.” J Powell
Article By:
Michele Schneider
Read
Monday, May 13, 2024 5:12 AM EDT
Stagflation-Last week Jerome Powell said he sees neither a chance of stagnation nor inflation.
Charles Payne asked me about why I call this the new “transitory.”
I begin with Shakespeare- “…Doth protest too much.”
Healthcare And Biotech Investing 101: What You Need To Know.
Article By:
Rod Raynovich
Read
Monday, May 13, 2024 4:44 AM EDT
Healthcare as a sector represents only about 12% of the S&P 500. If you want to overweight healthcare as a sector you need to add equities. Healthcare is usually a defensive sector because of demographics and government funding through Medicare.
Current Analysis: CompuGroup Medical (CMPVF)
Article By:
Fredrik Arnold
Read
Monday, May 13, 2024 12:02 AM EDT
CompuGroup is a 37-year-old dividend paying Koblenz Germany-based healthcare digital communications firm.
In this article: CMPVF